Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cellebrite DI (CLBT)
NASDAQ:CLBT
Holding CLBT?
Track your performance easily
Earnings Data
Report Date
Feb 12, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.06Last Year’s EPS
-$0.08Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 06, 2024
|% Change Since: 13.05%
|Next Earnings Date:Feb 12, 2025
Earnings Call Sentiment|Positive
Cellebrite delivered a strong financial performance in Q3 2024, with record revenue and ARR growth, high profitability, and significant expansion in the federal sector. The announcement of the CEO transition introduces some uncertainty but does not outweigh the positive financial and operational achievements.Company Guidance
During the Cellebrite Third Quarter 2024 Financial Results Conference Call, guidance was provided with an emphasis on key financial metrics and future strategies. The company surpassed $100 million in quarterly revenue for the first time, driven by a 27% increase in subscription revenue, contributing to a 26% year-on-year ARR growth, reaching $371 million. Gross margin was reported at 86.1%, with adjusted EBITDA at $31.3 million, reflecting a 29% margin. In terms of geographical revenue distribution, the Americas accounted for 54% of ARR, with substantial growth in the U.S. Federal sector. Looking ahead, Cellebrite raised its 2024 revenue target to between $397 million and $401 million and expects to end the year with ARR around $390 million. The company remains committed to achieving Rule of 45 performance, with plans to further expand its sales force and enhance cloud-based solutions, particularly within its AI-driven C2C platform.Record Quarterly Revenue
Cellebrite surpassed $100 million in quarterly revenue for the first time in the company's history, reaching $106.8 million, marking a 27% growth year-over-year.
Strong ARR Growth
Annual Recurring Revenue (ARR) grew by 26% year-on-year to $371 million at the end of September 2024.
High Gross Margins and Profitability
Non-GAAP gross margins were 86.1%, and adjusted EBITDA was $31.3 million, or 29% on a margin basis.
Expansion in the Federal Sector
Cellebrite Federal Solutions launched to expand relationships with the U.S. federal government, showing excellent Q3 performance in this sector.
Guardian SaaS Growth
Guardian grew by more than 100% over the past 12 months, transforming how customers manage and share digital evidence.
Positive Cash Flow
Ended September with $413.6 million in cash, cash equivalents, and investments, an increase of $47.6 million from the second quarter.
---
CLBT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CLBT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2024 | $19.15 | $19.09 | -0.31% |
| Aug 15, 2024 | $13.94 | $14.96 | +7.32% |
| May 23, 2024 | $11.61 | $11.88 | +2.33% |
| Feb 15, 2024 | $9.68 | $10.74 | +10.95% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Cellebrite DI (CLBT) report earnings?
Cellebrite DI (CLBT) is schdueled to report earning on Feb 12, 2025, TBA Not Confirmed.
What is Cellebrite DI (CLBT) earnings time?
Cellebrite DI (CLBT) earnings time is at Feb 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CLBT EPS forecast?
CLBT EPS forecast for the fiscal quarter 2024 (Q4) is $0.06.
---